Quelling of Excitotoxicity in Acute Stroke With Ketamine

Phase: PHASE2, PHASE3 | Sponsor: Lower Merion Neurology Research Foundation | Compound: Ketamine

Status

planned

Institution

Lower Merion Neurology Research Foundation

Start date

2024-07-01

End date

2027-12-31

Registry ID

NCT03223220

View trial record

Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.